Evidence map›Paper›PMID 25675494›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2015

Oxalic acid and diacylglycerol 36:3 are cross-species markers of sleep debt.

Aalim M Weljie, Peter Meerlo, Namni Goel, Arjun Sengupta, Matthew S Kayser, Ted Abel, Morris J Birnbaum, David F Dinges, Amita Sehgal

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 159 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Gene-by-Sleep Duration Interaction for Glycemic Traits in over 480,000 Individuals.medRxiv : the preprint server for health sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Anthropogenic disturbance affects calling and collective behaviour in corvid roosts.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  18. Article
  19. Review
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Aalim M WeljieDepartment of Pharmacology, amita@mail.med.upenn.edu aalim@upenn.edu.
Peter MeerloCenter for Behavior and Neurosciences, University of Groningen, 9747 AG Groningen, The Netherlands.
Namni GoelDepartment of Psychiatry, Center for Sleep and Circadian Neurobiology.
Arjun SenguptaDepartment of Pharmacology.
Matthew S KayserDepartment of Psychiatry, Center for Sleep and Circadian Neurobiology.
Ted AbelDepartment of Biology, University of Pennsylvania School of Arts and Science, and.
Morris J BirnbaumThe Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania Perelman School of Medicine.
David F DingesDepartment of Psychiatry, Center for Sleep and Circadian Neurobiology.
Amita SehgalProgram in Chronobiology, Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, PA 19104; and amita@mail.med.upenn.edu aalim@upenn.edu.
Canadian Sleep & Circadian Network · CAUniversity of Pennsylvania · USUniversity of Groningen · NL

Funding

Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
TRAINING PROGRAM/RESPIRATORY NEUROBIOLOGY AND SLEEPT32HL007713 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN I · 1992 to 2022
$11.9M
NEUROBEHAVIORAL EFFECTS OF PARTIAL SLEEP DEPRIVATIONR01NR004281 · NINR · UNIVERSITY OF PENNSYLVANIA · PI DINGES, DAVID F · 1995 to 2014
$7.9M
A critical period of sleep required for normal brain developmentK08NS090461 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI KAYSER, MATTHEW S · 2014 to 2018
$952k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1TR000003NHLBI NIH HHS T32 HL007713NINDS NIH HHS K08 NS090461NINR NIH HHS R01 NR004281
6 · The paper itself

Abstract

Sleep is an essential biological process that is thought to have a critical role in metabolic regulation. In humans, reduced sleep duration has been associated with risk for metabolic disorders, including weight gain, diabetes, obesity, and cardiovascular disease. However, our understanding of the molecular mechanisms underlying effects of sleep loss is only in its nascent stages. In this study we used rat and human models to simulate modern-day conditions of restricted sleep and addressed cross-species consequences via comprehensive metabolite profiling. Serum from sleep-restricted rats was analyzed using polar and nonpolar methods in two independent datasets (n = 10 per study, 3,380 measured features, 407 identified). A total of 38 features were changed across independent experiments, with the majority classified as lipids (18 from 28 identified). In a parallel human study, 92 metabolites were identified as potentially significant, with the majority also classified as lipids (32 of 37 identified). Intriguingly, two metabolites, oxalic acid and diacylglycerol 36:3, were robustly and quantitatively reduced in both species following sleep restriction, and recovered to near baseline levels after sleep restriction (P < 0.05, false-discovery rate < 0.2). Elevated phospholipids were also noted after sleep restriction in both species, as well as metabolites associated with an oxidizing environment. In addition, polar metabolites reflective of neurotransmitters, vitamin B3, and gut metabolism were elevated in sleep-restricted humans. These results are consistent with induction of peroxisome proliferator-activated receptors and disruptions of the circadian clock. The findings provide a potential link between known pathologies of reduced sleep duration and metabolic dysfunction, and potential biomarkers for sleep loss.

Indexed as

AnimalsBiomarkersCircadian RhythmDiglyceridesDisease Models, AnimalEnergy MetabolismFemaleGastrointestinal TractHumansMaleMetabolomeMetabolomicsMicrobiotaMiddle AgedNeurotransmitter AgentsNiacinamide1,2-diacylglycerolBiomarkersDiglyceridesNeurotransmitter AgentsNiacinamideOxalic AcidPPAR gammalipidomicsmass spectrometrymetabolomicssleep deprivationsleep restriction

Identifiers

PMID25675494
PMCPMC4345602
OpenAlexW1981928051

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.